Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tanyaradzwa P. Ndongwe"'
Autor:
Dandan Liu, Philip R. Tedbury, Shuiyun Lan, Andrew D. Huber, Maritza N. Puray-Chavez, Juan Ji, Eleftherios Michailidis, Mohsan Saeed, Tanyaradzwa P. Ndongwe, Leda C. Bassit, Raymond F. Schinazi, Robert Ralston, Charles M. Rice, Stefan G. Sarafianos
Publikováno v:
Viruses, Vol 11, Iss 11, p 1039 (2019)
RNA viruses are highly successful pathogens and are the causative agents for many important diseases. To fully understand the replication of these viruses it is necessary to address the roles of both positive-strand RNA ((+)RNA) and negative-strand R
Externí odkaz:
https://doaj.org/article/4a53a406145a400985558c05b4268e77
Autor:
Maritza N. Puray-Chavez, Mahmoud H. Farghali, Vincent Yapo, Andrew D. Huber, Dandan Liu, Tanyaradzwa P. Ndongwe, Mary C. Casey, Thomas G. Laughlin, Mark Hannink, Philip R. Tedbury, Stefan G. Sarafianos
Publikováno v:
Viruses, Vol 11, Iss 7, p 651 (2019)
Moloney leukemia virus 10 (MOV10) is an RNA helicase that has been shown to affect the replication of several viruses. The effect of MOV10 on Hepatitis B virus (HBV) infection is not known and its role on the replication of this virus is poorly under
Externí odkaz:
https://doaj.org/article/c0273300415d4e34949dd9d7ffb4f932
Autor:
Dandan Liu, Tanyaradzwa P. Ndongwe, Maritza Puray-Chavez, Philip R. Tedbury, Vinay K. Pathak, Mary C. Casey, Taisuke Izumi, Stefan G. Sarafianos
Publikováno v:
FASEB J
Mov10 is a processing body (P-body) protein and an interferon-stimulated gene that can affect replication of retroviruses, hepatitis B virus, and hepatitis C virus (HCV). The mechanism of HCV inhibition by Mov10 is unknown. Here, we investigate the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6302f38e6476927a46578f3ec15134c5
https://europepmc.org/articles/PMC8214447/
https://europepmc.org/articles/PMC8214447/
Autor:
Tanyaradzwa P. Ndongwe, Vincent Yapo, Maritza Puray-Chavez, Mark Hannink, Mahmoud H. Farghali, Thomas G. Laughlin, Philip R. Tedbury, Dandan Liu, Mary C. Casey, Andrew D. Huber, Stefan G. Sarafianos
Publikováno v:
Viruses
Volume 11
Issue 7
Viruses, Vol 11, Iss 7, p 651 (2019)
Volume 11
Issue 7
Viruses, Vol 11, Iss 7, p 651 (2019)
Moloney leukemia virus 10 (MOV10) is an RNA helicase that has been shown to affect the replication of several viruses. The effect of MOV10 on Hepatitis B virus (HBV) infection is not known and its role on the replication of this virus is poorly under
Autor:
Leda Bassit, Juan Ji, Mohsan Saeed, Charles M. Rice, Stefan G. Sarafianos, Eleftherios Michailidis, Tanyaradzwa P. Ndongwe, Maritza Puray-Chavez, Shuiyun Lan, Robert Ralston, Dandan Liu, Andrew D. Huber, Philip R. Tedbury, Raymond F. Schinazi
Publikováno v:
Viruses
Volume 11
Issue 11
Viruses, Vol 11, Iss 11, p 1039 (2019)
Volume 11
Issue 11
Viruses, Vol 11, Iss 11, p 1039 (2019)
RNA viruses are highly successful pathogens and are the causative agents for many important diseases. To fully understand the replication of these viruses it is necessary to address the roles of both positive-strand RNA ((+)RNA) and negative-strand R
Autor:
Stefan G. Sarafianos, Tanyaradzwa P. Ndongwe, Charles M. Rice, Dandan Liu, Eleftherios Michailidis, Robert Ralston, Juan Ji
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:3482-3492
While earlier therapeutic strategies for the treatment of hepatitis C virus (HCV) infection relied exclusively on interferon (IFN) and ribavirin (RBV), four direct-acting antiviral agents (DAAs) have now been approved, aiming for an interferon-free s
Autor:
Stefan G. Sarafianos, Kamalendra Singh, Maxwell D. Leslie, Michael A. Parniak, Tanyaradzwa P. Ndongwe, Karen A. Kirby, Tracy L. Fetterly, Christopher A. Dorst, Eleftherios Michailidis, Atsuko Hachiya, Daniel V. Sietsema, Yee Tsuey Ong, Zhengqiang Wang, Bruno Marchand
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:2048-2061
RNase H inhibitors (RNHIs) have gained attention as potential HIV-1 therapeutics. Although several RNHIs have been studied in the context of HIV-1 reverse transcriptase (RT) RNase H, there is no information on inhibitors that might affect the RNase H
Autor:
Marc C. Johnson, Kamalendra Singh, Vinay K. Pathak, Tanyaradzwa P. Ndongwe, Yi Min Zheng, Michael A. Parniak, Stefan G. Sarafianos, Bruno Marchand, Krista A. Delviks-Frankenberry, Shilei Ding, Karen A. Kirby, Emily M. Ryan, Hiroaki Mitsuya, Shan-Lu Liu, Angela S. Whatley, Devendra K. Rai, Eiichi Kodama, Eleftherios Michailidis, Yee Tsuey Ong, Adeyemi O. Adedeji, Atsuko Hachiya, Donald H. Burke
Publikováno v:
Nucleic Acids Research
We report key mechanistic differences between the reverse transcriptases (RT) of human immunodeficiency virus type-1 (HIV-1) and of xenotropic murine leukemia virus-related virus (XMRV), a gammaretrovirus that can infect human cells. Steady and pre-s